Sign in
4

Changes in Ownership

Camp4 Therapeutics Corp Filed Acc 0001628280-25-016481

Options or other derivatives

  • Chief Executive Officer acquired 160,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Mandel-Brehm Josh · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-04-01 Grant or award : show line 1 in the form Stock Option (Right to Buy) +160,000 160,000 D
Loading xslF345X05/wk-form4_1743710748.xml…